MedPath

Vasoactive Peptides in Portal Pressure

Not Applicable
Conditions
Portal Hypertension
Registration Number
NCT00163982
Lead Sponsor
Bayside Health
Brief Summary

This study is looking at the detection of vasoactive peptides in portal hypertension.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • HVPG >= 12 mmHg
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Alfred Hospital

🇦🇺

Melbourne, Victoria, Australia

© Copyright 2025. All Rights Reserved by MedPath